Related references
Note: Only part of the references are listed.Successful treatment with rivaroxaban of an extended deep vein thrombosis complicated by pulmonary embolismin a patient with familial antithrombin III deficiency: a case report
Marianna Appignani et al.
EUROPEAN HEART JOURNAL-CASE REPORTS (2020)
Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
Jenny E. Kanter et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Selecting analytical biomarkers for diagnostic applications: a first principles approach
Samantha A. Byrnes et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
Coagulation factor XII in thrombosis and inflammation
Coen Maas et al.
BLOOD (2018)
Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin-activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different invitro models
D. Leenaerts et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
R-SCAN: CT Angiographic Imaging for Pulmonary Embolism
L. Alexandre Frigini et al.
JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY (2017)
Incidence of acute pulmonary embolism, related comorbidities and survival; analysis of a Swedish national cohort
Therese Andersson et al.
BMC CARDIOVASCULAR DISORDERS (2017)
Proteomic profiling identifies N-acetylmuramoyl-L-alanine amidase as a novel biomarker of sepsis
Fabiano Pinheiro da Silva et al.
BIOMARKERS IN MEDICINE (2016)
Carboxylic ester hydrolases: Classification and database derived from their primary, secondary, and tertiary structures
Yingfei Chen et al.
PROTEIN SCIENCE (2016)
Pulmonary embolism: the diagnosis, risk-stratification, treatment and disposition of emergency department patients
Daniel Corrigan et al.
CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE (2016)
Afamin - A pleiotropic glycoprotein involved in various disease states
Hans Dieplinger et al.
CLINICA CHIMICA ACTA (2015)
Complement activation in diseases presenting with thrombotic microangiopathy
Seppo Meri
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2013)
Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis
Satoshi Serada et al.
INFLAMMATORY BOWEL DISEASES (2012)
Performance of the Pulmonary Embolism Rule-out Criteria (the PERC rule) combined with low clinical probability in high prevalence population
Andrea Penaloza et al.
THROMBOSIS RESEARCH (2012)
CTPA as the gold standard for the diagnosis of pulmonary embolism
Rosa M. Estrada-Y-Martin et al.
INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY (2011)
Complement activation on platelets: Implications for vascular inflammation and thrombosis
Ellinor I. Peerschke et al.
MOLECULAR IMMUNOLOGY (2010)
Factor XII: What does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis
Evi Stavrou et al.
THROMBOSIS RESEARCH (2010)
Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?
J. L. Willemse et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Recurrent CT, Cumulative Radiation Exposure, and Associated Radiation-induced Cancer Risks from CT of Adults
Aaron Sodickson et al.
RADIOLOGY (2009)
Current concepts - Computed tomography - An increasing source of radiation exposure
David J. Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Detection of Venous Thromboembolism by Proteomic Serum Biomarkers
Santhi K. Ganesh et al.
PLOS ONE (2007)
Complement and coagulation: strangers or partners in crime?
Maciej M. Markiewski et al.
TRENDS IN IMMUNOLOGY (2007)
Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism
JA Chirinos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)